Your session is about to expire
← Back to Search
Mindfulness Based Intervention for Primary Biliary Cirrhosis
Study Summary
This trial is testing whether a mindfulness-based intervention can help reduce fatigue in patients with primary biliary cholangitis.
- Primary Biliary Cirrhosis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a medical condition like anemia, thyroid problems, kidney disease, or untreated depression that can cause fatigue.You currently use drugs or alcohol, or have a history of drug or stimulant abuse.You have ongoing bleeding from swollen blood vessels, fluid buildup in your abdomen that doesn't respond to medication, or sudden brain problems without an obvious cause.You have made changes to your treatment for primary biliary cholangitis (PBC) in the last six months.You have other serious health conditions, like advanced cancer or severe heart or lung disease, that may shorten your lifespan.You have been diagnosed with a liver disease called Primary Biliary Cholangitis based on specific medical criteria.You have a history of mental illness that includes experiencing hallucinations or delusions.
- Group 1: Stress in Control for Healthy Liver (SynC-HL) Intervention:
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the pre-determined criteria for eligibility in this trial?
"This clinical study is recruiting 20 patients with cholangitis who are between 18 and 75 years of age. In order to be accepted, potential volunteers must demonstrate their capacity for informed consent, have been receiving UDCA therapy for at least 6 months prior to enrollment, and possess a PBC-40 fatigue domain score of over 33."
What is the maximum capacity of this scientific study?
"Affirmative. According to clinicaltrials.gov, this medical study has been actively recruiting patients since its initial posting on November 19th 2018 and was most recently updated on August 26th 2022. The trial is searching for 20 individuals from one location specifically."
Does this research endeavor include individuals aged sixty and above?
"According to the inclusion requirements of this clinical trial, participants must be at least 18 years old and no older than 75."
Are there any available slots for enrollment in this research?
"Indeed, this research endeavour is actively recruiting new participants. The original posting date of the study was November 19th 2018 and the information has been updated as recently as August 26th 2022 on clinicaltrials.gov."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger